These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 11259330)
1. Uptake of teicoplanin by isolated rat hepatocytes: comparison with in vivo hepatic distribution. Reinoso RF; Telfer BA; Brennan BS; Rowland M Drug Metab Dispos; 2001 Apr; 29(4 Pt 1):453-9. PubMed ID: 11259330 [TBL] [Abstract][Full Text] [Related]
2. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice. Marsman D Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194 [TBL] [Abstract][Full Text] [Related]
3. Effect of macrolide antibiotics on uptake of digoxin into rat liver. Ito S; Nasu R; Tsujimoto M; Murakami H; Ohtani H; Sawada Y Biopharm Drug Dispos; 2007 Apr; 28(3):113-23. PubMed ID: 17253595 [TBL] [Abstract][Full Text] [Related]
4. Uptake by mouse liver and intracellular fate of plasmid DNA after a rapid tail vein injection of a small or a large volume. Lecocq M; Andrianaivo F; Warnier MT; Wattiaux-De Coninck S; Wattiaux R; Jadot M J Gene Med; 2003 Feb; 5(2):142-56. PubMed ID: 12539152 [TBL] [Abstract][Full Text] [Related]
5. In vitro studies of teicoplanin binding to rat tissues and erythrocytes. Reinoso RF; Telfer BA; Rowland M Eur J Pharm Sci; 1998 Apr; 6(2):145-52. PubMed ID: 9925429 [TBL] [Abstract][Full Text] [Related]
6. Uptake and intracellular binding of lipophilic amine drugs by isolated rat hepatocytes and implications for prediction of in vivo metabolic clearance. Hallifax D; Houston JB Drug Metab Dispos; 2006 Nov; 34(11):1829-36. PubMed ID: 16882765 [TBL] [Abstract][Full Text] [Related]
7. Characterization of S-adenosylhomocysteine binding to isolated rat hepatocytes and purified rat liver plasma membranes. Effect of analogues of S-adenosylhomocysteine. Ueland PM; Aarbakke J; Bessesen A Mol Pharmacol; 1982 Jan; 21(1):108-13. PubMed ID: 7132953 [TBL] [Abstract][Full Text] [Related]
8. Correlation between in vivo and in vitro hepatic uptake of metabolic inhibitors of cytochrome P-450 in rats. Yamano K; Yamamoto K; Kotaki H; Takedomi S; Matsuo H; Sawada Y; Iga T Drug Metab Dispos; 1999 Nov; 27(11):1225-31. PubMed ID: 10534305 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics, blood partition and protein binding of DA-7867, a new oxazolidinone. Bae SK; Chung WS; Kim EJ; Rhee JK; Kwon JW; Kim WB; Lee MG Biopharm Drug Dispos; 2004 Apr; 25(3):127-35. PubMed ID: 15083501 [TBL] [Abstract][Full Text] [Related]
10. Kinetics of drug metabolism in rat liver slices. III. Relationship between metabolic clearance and slice uptake rate. Worboys PD; Bradbury A; Houston JB Drug Metab Dispos; 1997 Apr; 25(4):460-7. PubMed ID: 9107546 [TBL] [Abstract][Full Text] [Related]
11. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653 [TBL] [Abstract][Full Text] [Related]
12. Effect of plasma protein binding on in vitro-in vivo correlation of biliary excretion of drugs evaluated by sandwich-cultured rat hepatocytes. Fukuda H; Ohashi R; Tsuda-Tsukimoto M; Tamai I Drug Metab Dispos; 2008 Jul; 36(7):1275-82. PubMed ID: 18388177 [TBL] [Abstract][Full Text] [Related]
13. Prediction of the hepatic and renal clearance of transporter substrates in rats using in vitro uptake experiments. Watanabe T; Maeda K; Kondo T; Nakayama H; Horita S; Kusuhara H; Sugiyama Y Drug Metab Dispos; 2009 Jul; 37(7):1471-9. PubMed ID: 19364828 [TBL] [Abstract][Full Text] [Related]
14. Caffeine potentiation of allyl alcohol-induced hepatotoxicity. II. In vitro study. Karas M; Chakrabarti SK J Environ Pathol Toxicol Oncol; 2001; 20(2):155-64. PubMed ID: 11394714 [TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo correlation of hepatic transporter effects on erythromycin metabolism: characterizing the importance of transporter-enzyme interplay. Lam JL; Okochi H; Huang Y; Benet LZ Drug Metab Dispos; 2006 Aug; 34(8):1336-44. PubMed ID: 16698890 [TBL] [Abstract][Full Text] [Related]
16. Radiolabeled constructs for evaluation of the asialoglycoprotein receptor status and hepatic functional reserves. Abe M; Lai J; Kortylewicz ZP; Nagata H; Fox IJ; Enke CA; Baranowska-Kortylewicz J Bioconjug Chem; 2003; 14(5):997-1006. PubMed ID: 13129404 [TBL] [Abstract][Full Text] [Related]
17. A nanoparticle-based model delivery system to guide the rational design of gene delivery to the liver. 2. In vitro and in vivo uptake results. Popielarski SR; Hu-Lieskovan S; French SW; Triche TJ; Davis ME Bioconjug Chem; 2005; 16(5):1071-80. PubMed ID: 16173782 [TBL] [Abstract][Full Text] [Related]
18. Teicoplanin population pharmacokinetic analysis in hospitalized patients. Soy D; López E; Ribas J Ther Drug Monit; 2006 Dec; 28(6):737-43. PubMed ID: 17164688 [TBL] [Abstract][Full Text] [Related]
19. Prediction of the pharmacokinetics of atorvastatin, cerivastatin, and indomethacin using kinetic models applied to isolated rat hepatocytes. Paine SW; Parker AJ; Gardiner P; Webborn PJ; Riley RJ Drug Metab Dispos; 2008 Jul; 36(7):1365-74. PubMed ID: 18426955 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic-pharmacodynamic aspects of antimicrobial prophylaxis with teicoplanin in patients undergoing major vascular surgery. Pea F; Furlanut M; Stellini R; Bonardelli S; Signorini L; Pavan F; Matheis A; Portolani N; Lorenzotti S; Giulini SM; Viale P; Carosi G Int J Antimicrob Agents; 2006 Jan; 27(1):15-9. PubMed ID: 16343858 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]